| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.51B | +7.4% |
| R&D Expense | $123.0M | +9.8% |
| Operating Income | $938.0M | +14.4% |
| Pre-tax Income | $739.0M | +46.0% |
| Income Tax | $189.0M | +231.6% |
| Net Income | $506.0M | +21.3% |
| EPS (Basic) | $6.93 | +19.7% |
| EPS (Diluted) | $6.75 | +19.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $916.0M | -4.4% |
| Accounts Receivable | $1.26B | +3.7% |
| Inventory | $880.0M | +11.7% |
| Current Assets | $3.40B | +1.7% |
| Total Assets | $5.16B | +1.8% |
| Current Liabilities | $1.70B | -9.1% |
| Long-term Debt | $1.59B | -13.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $792.0M | -4.8% |
| Capital Expenditures | $299.0M | +43.1% |
| Investing Cash Flow | -$293.0M | -1.4% |
| Financing Cash Flow | -$511.0M | +0.6% |
| Free Cash Flow | $493.0M | -20.9% |
| Total Liabilities |
| $3.88B |
| -6.5% |
| Stockholders' Equity | $1.28B | +39.1% |